Wordt geladen...
Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect
Liraglutide has shown favourable effects on several cardiometabolic risk factors, beyond glucose control. MicroRNAs (miRNAs) regulate gene expression, resulting in post-transcriptional modifications of cell response and function. Specific miRNAs, including miRNA-27b, miRNA-130a, and miRNA-210, play...
Bewaard in:
| Gepubliceerd in: | Metabolites |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7599907/ https://ncbi.nlm.nih.gov/pubmed/33008044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10100391 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|